(Total Views: 84)
Posted On: 01/06/2017 3:01:17 PM
Post# of 22711
![Avatar](https://investorshangout.com/images/ProfileImages/1188589070_11430_money.png)
$RNVA getting ready for next week.
10:12 AM EST, 01/06/2017 (MT Newswires) -- Rennova Health (RNVA) said Friday the company expects continued expansion of its customer base and products, combined with an increasing number of contracts with various payers, resulting in 2017 revenue growth resembling years prior to 2016.
The company said it has moved from a concentration in substance abuse testing services in a single geographic location to providing a range of diagnostic services across the U.S. to an expanding and varied customer base.
Additionally, Rennova has initiated a relationship with a clinical research organization and expects to begin generating sales from this partnership the first half of 2017.
Rennova also said it has secured a contract with a service-disabled, veteran-owned small business to be their exclusive provider of lab services, and has also extended its services to include specialized pharmacogenomics testing for personalized medicine through Genomas.
Price: 0.09, Change: , Percent Change: +3.15
http://www.mtnewswires.com Copyright © 2017 MTNewswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
10:12 AM EST, 01/06/2017 (MT Newswires) -- Rennova Health (RNVA) said Friday the company expects continued expansion of its customer base and products, combined with an increasing number of contracts with various payers, resulting in 2017 revenue growth resembling years prior to 2016.
The company said it has moved from a concentration in substance abuse testing services in a single geographic location to providing a range of diagnostic services across the U.S. to an expanding and varied customer base.
Additionally, Rennova has initiated a relationship with a clinical research organization and expects to begin generating sales from this partnership the first half of 2017.
Rennova also said it has secured a contract with a service-disabled, veteran-owned small business to be their exclusive provider of lab services, and has also extended its services to include specialized pharmacogenomics testing for personalized medicine through Genomas.
Price: 0.09, Change: , Percent Change: +3.15
http://www.mtnewswires.com Copyright © 2017 MTNewswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)